Evidence map›Paper›PMID 39268309›Full record

ArticleCureus2024

Clinical Benefits of Octreotide for Managing Persistent Gastrointestinal Fluid Loss in Malignant Small Bowel Obstruction: A Case Report and Literature Review.

Chalothorn Wannaphut, Landon A Kozai, Narathorn Kulthamrongsri, Chutawat Kookanok, Wanprapit Noree, Kamonluk Rodsom, Ekamol Tantisattamo, Jared Acoba

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chalothorn WannaphutDepartment of Internal Medicine, University of Hawai'i John A. Burns School of Medicine, Honolulu, USA.
Landon A KozaiDepartment of Internal Medicine, University of Hawai'i John A. Burns School of Medicine, Honolulu, USA.
Narathorn KulthamrongsriDepartment of Medicine, American Heart Association Comprehensive Hypertension Center, University of California Irvine Medical Center, Orange, USA.
Chutawat KookanokDepartment of Internal Medicine, Phramongkutklao College of Medicine, Mahidol University, Bangkok, THA.
Wanprapit NoreeDepartment of Medicine, American Heart Association Comprehensive Hypertension Center, University of California Irvine Medical Center, Orange, USA.
Kamonluk RodsomDepartment of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, THA.
Ekamol TantisattamoDivision of Nephrology, Hypertension and Kidney Transplantation, University of California Irvine School of Medicine, Orange, USA.
Jared AcobaDepartment of Hematology and Oncology, The Queen's Medical Center, Honolulu, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant small bowel obstruction (mSBO) is a frequent complication in patients with gastrointestinal or gynecologic cancers. For those with inoperable cancers and persistent obstructive symptoms, symptom palliation with a percutaneous gastrostomy tube (PGT) may be required. However, excessive fluid loss from the PGT can lead to significant fluid, electrolyte, and acid-base imbalances. We present a case of a man with metastatic colonic adenocarcinoma who developed mSBO, acute kidney injury, and metabolic alkalosis, all of which were effectively managed with octreotide.

Indexed as

acute kidney injurygastrointestinal fluid lossmalignant small bowel obstructionmetabolic alkalosisoctreotide

Identifiers

PMID39268309
PMCPMC11392515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.